Back to team page

Andy Hill

BSc (Hons) MBA

Andy is Director of Business Development – Medtech at Sensyne Health, where he is responsible for establishing and supporting Sensyne’s commercial relationships with medical technology firms.

Andy is also the Sensyne Health Expert in Residence (EIR) for LAB10x, an Oxford-based digital health technology business incubator formed through a collaboration between Sensyne Health, Evotec, the University of Oxford, Oxford University Innovation and Oxford Sciences Innovation.

Andy is a life-sciences graduate from the University of Durham and MBA with over 30 years’ experience in the medical technology industry as an executive and entrepreneur.

His background is in sales, marketing and general management and he has a track record in the introduction of new and disruptive medical technologies into Europe and the USA. Andy built the European businesses (from first in human use to exit) for two Silicon Valley-based start-ups and has led businesses as a CEO across a diverse range of sectors including patient monitoring, imaging, regenerative medicine and AI. He was CEO and cofounding investor in an Oxford University imaging/AI spinout that was subsequently acquired in 2017.